These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6297806)

  • 1. Suppression of cell-mediated immunity to challenge with P 815 mastocytoma in concanavalin A-treated mice.
    Ekstedt RD; Merdian DJ
    Cell Immunol; 1983 Jan; 75(1):181-7. PubMed ID: 6297806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of concanavalin A treatment on the allogeneic response of mice to challenge with P 815 mastocytoma: interleukin 2 treatment reverses concanavalin A suppression in vivo.
    Ekstedt RD; Merdian DJ
    Cell Immunol; 1984 May; 85(2):447-58. PubMed ID: 6424952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastocytoma-medicated suppression of mixed lymphocyte culture and mitogen responsiveness.
    DeLustro F; Argyris BF
    Cell Immunol; 1976 Jan; 21(1):177-84. PubMed ID: 129285
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
    Warren HS; Woolnough JA; Lafferty KJ
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of peritoneal macrophages in cellular responses to mastocytoma in resistant and susceptible mice.
    Farber P; Specter S; Friedman H
    Adv Exp Med Biol; 1979; 121B():521-30. PubMed ID: 121034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of lymphocyte signal transduction by murine mastocytoma ascites.
    Ding L; Isobe K; Yoshida T; Nakashima I
    Microbiol Immunol; 1991; 35(9):767-74. PubMed ID: 1808472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.
    Waterfield JD; Waterfield EM; Möller G
    Cell Immunol; 1975 Jun; 17(2):392-404. PubMed ID: 805001
    [No Abstract]   [Full Text] [Related]  

  • 12. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous silica on immune and non-immune functions of the murine host.
    Levy MH; Wheelock EF
    J Immunol; 1975 Jul; 115(1):41-8. PubMed ID: 239057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response against tumor cells. I. In vitro immunization of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells.
    Lundak RL; Raidt DJ
    Cell Immunol; 1973 Oct; 9(1):60-6. PubMed ID: 4270287
    [No Abstract]   [Full Text] [Related]  

  • 18. A high frequency of cytotoxic precursor cells for a syngeneic tumour.
    Warren HS; Lafferty KJ
    Scand J Immunol; 1979; 10(4):349-52. PubMed ID: 119310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decay of memory of cell-mediated cytotoxicity after primary sensitization in vivo against a tumor allograft.
    Jones KH; Adler WH
    Immunol Commun; 1978; 7(6):645-59. PubMed ID: 154468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative approaches to the assessment of cell-mediated immune responses to solid tumor allografts.
    MacDonald HR; Lees RK; Howell RL
    Transplant Proc; 1978 Jun; 10(2):339-42. PubMed ID: 97826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.